IE35439B1 - Labelled sulphated polysaccharide compositions - Google Patents
Labelled sulphated polysaccharide compositionsInfo
- Publication number
- IE35439B1 IE35439B1 IE862/71A IE86271A IE35439B1 IE 35439 B1 IE35439 B1 IE 35439B1 IE 862/71 A IE862/71 A IE 862/71A IE 86271 A IE86271 A IE 86271A IE 35439 B1 IE35439 B1 IE 35439B1
- Authority
- IE
- Ireland
- Prior art keywords
- compositions
- labelled
- sulphated
- sulphated polysaccharide
- iodine
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 150000004676 glycans Chemical class 0.000 title abstract 2
- 229920001282 polysaccharide Polymers 0.000 title abstract 2
- 239000005017 polysaccharide Substances 0.000 title abstract 2
- PNDPGZBMCMUPRI-HVTJNCQCSA-N 10043-66-0 Chemical compound [131I][131I] PNDPGZBMCMUPRI-HVTJNCQCSA-N 0.000 abstract 1
- 229920000945 Amylopectin Polymers 0.000 abstract 1
- GKLVYJBZJHMRIY-OUBTZVSYSA-N Technetium-99 Chemical compound [99Tc] GKLVYJBZJHMRIY-OUBTZVSYSA-N 0.000 abstract 1
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 239000000975 dye Substances 0.000 abstract 1
- 238000003384 imaging method Methods 0.000 abstract 1
- 229940044173 iodine-125 Drugs 0.000 abstract 1
- ZCYVEMRRCGMTRW-YPZZEJLDSA-N iodine-125 Chemical compound [125I] ZCYVEMRRCGMTRW-YPZZEJLDSA-N 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- CXKWCBBOMKCUKX-UHFFFAOYSA-M methylene blue Chemical compound [Cl-].C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 CXKWCBBOMKCUKX-UHFFFAOYSA-M 0.000 abstract 1
- 229960000907 methylthioninium chloride Drugs 0.000 abstract 1
- 229920001592 potato starch Polymers 0.000 abstract 1
- 230000005855 radiation Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229940056501 technetium 99m Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/006—Biological staining of tissues in vivo, e.g. methylene blue or toluidine blue O administered in the buccal area to detect epithelial cancer cells, dyes used for delineating tissues during surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/06—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Optics & Photonics (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Heart & Thoracic Surgery (AREA)
- Dispersion Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5270770A | 1970-07-06 | 1970-07-06 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE35439L IE35439L (en) | 1972-01-06 |
| IE35439B1 true IE35439B1 (en) | 1976-02-18 |
Family
ID=21979383
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE862/71A IE35439B1 (en) | 1970-07-06 | 1971-07-06 | Labelled sulphated polysaccharide compositions |
Country Status (12)
| Country | Link |
|---|---|
| BE (1) | BE769554A (enExample) |
| CA (1) | CA946741A (enExample) |
| CH (1) | CH565559A5 (enExample) |
| DE (1) | DE2133005A1 (enExample) |
| ES (1) | ES392966A1 (enExample) |
| FR (1) | FR2100869B1 (enExample) |
| GB (1) | GB1355559A (enExample) |
| IE (1) | IE35439B1 (enExample) |
| IL (1) | IL37244A (enExample) |
| NL (1) | NL7109318A (enExample) |
| SE (1) | SE399821B (enExample) |
| ZA (1) | ZA714438B (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5672334A (en) * | 1991-01-16 | 1997-09-30 | Access Pharmaceuticals, Inc. | Invivo agents comprising cationic metal chelators with acidic saccharides and glycosaminoglycans |
| US5310538A (en) * | 1993-03-11 | 1994-05-10 | Sterling Winthrop Inc. | Compositions of iodophenoxy alkylene ethers in film-forming materials for visualization of the gastrointestinal tract |
| US5312616A (en) * | 1993-03-11 | 1994-05-17 | Sterling Winthrop Inc. | Compositions of iodobenzoic acid derivatives in film-forming materials for visualization of the gastrointestinal tract |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE372421B (enExample) * | 1968-04-01 | 1974-12-23 | Minnesota Mining & Mfg |
-
1971
- 1971-07-02 DE DE19712133005 patent/DE2133005A1/de active Pending
- 1971-07-05 GB GB3139671A patent/GB1355559A/en not_active Expired
- 1971-07-06 IL IL37244A patent/IL37244A/en unknown
- 1971-07-06 IE IE862/71A patent/IE35439B1/xx unknown
- 1971-07-06 SE SE7108719A patent/SE399821B/xx unknown
- 1971-07-06 NL NL7109318A patent/NL7109318A/xx unknown
- 1971-07-06 BE BE769554A patent/BE769554A/xx unknown
- 1971-07-06 ES ES392966A patent/ES392966A1/es not_active Expired
- 1971-07-06 ZA ZA714438A patent/ZA714438B/xx unknown
- 1971-07-06 FR FR7124697A patent/FR2100869B1/fr not_active Expired
- 1971-07-06 CA CA117,489A patent/CA946741A/en not_active Expired
- 1971-07-06 CH CH989571A patent/CH565559A5/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| GB1355559A (en) | 1974-06-05 |
| IL37244A (en) | 1974-07-31 |
| ES392966A1 (es) | 1975-04-16 |
| IE35439L (en) | 1972-01-06 |
| CA946741A (en) | 1974-05-07 |
| FR2100869B1 (enExample) | 1974-09-06 |
| IL37244A0 (en) | 1971-10-20 |
| BE769554A (fr) | 1972-01-06 |
| DE2133005A1 (de) | 1972-01-20 |
| CH565559A5 (enExample) | 1975-08-29 |
| ZA714438B (en) | 1972-08-30 |
| FR2100869A1 (enExample) | 1972-03-24 |
| SE399821B (sv) | 1978-03-06 |
| NL7109318A (enExample) | 1972-01-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE28569T1 (de) | Zusammensetzung, die einen radiomarkierten antikoerper enthaelt, ausruestung zu ihrer herstellung und ausruestung zur krebs- oder tumorbestimmung, die diese zusammensetzung enthaelt. | |
| IE35326B1 (en) | Clathrate prostaglandins and compositions containing same | |
| HUP9802394A2 (hu) | Szulfatált oligoszacharidok és ezeket hatóanyagként tartalmazó gyógyszerkészítmények | |
| UA32577C2 (uk) | Радіомічена сполука для утворення зображення тромбів при радіонуклідній діагностиці, радіофармацевтичний препарат та радіофармацевтична композиція на їх основі та комплект для приготування радіофармацевтичних препаратів | |
| MX9709126A (es) | Reactivos estables para la preparacion de radiofarmacos. | |
| DE19875032I2 (de) | Mometason-Furoate-Monohydrat, Verfahren zu seiner Herstellung und das enthaltende pharmazeutische Zusammensetzungen | |
| GB1305442A (enExample) | ||
| IE35439B1 (en) | Labelled sulphated polysaccharide compositions | |
| IT1011320B (it) | Apparecchio per la preparazione di composizioni di radioisotopi ad esempio per diagnosi cliniche | |
| IL39735A (en) | 3,20-dioxo-pregn-4-ene-21-oic acid derivatives | |
| GB1361779A (en) | Vincamine salt and its use as a pharmaceutical composition | |
| GB1521712A (en) | 5-acetyl-4-hydroxy-2h-pyran-2,6(3h)dione derivatives and pharmaceutical compositions comprising such compounds | |
| DK128555B (da) | Fremgangsmåde til fremstilling af et diagnostisk præparat indeholdende et med <99>Tc mærket jernkompleks. | |
| GB1268188A (en) | N-hydroxyalkyl-2,4,6-triiodosuccinanilic acids and their use as x-ray contrast agents | |
| IE35428L (en) | Benzodiazepines. | |
| GB1493059A (en) | Anti-cancer compositions | |
| KR910002469A (ko) | 간.담도계 진단용 ^99mTC 표지 방사성의 약품의 제조방법 | |
| GB1346317A (en) | Peptide enzyme inhibitor | |
| GB1423482A (en) | 113m indium-acetyl acetonate and a medium for use in scinti graphic functional diagnosis of the liver | |
| GB1212119A (en) | Fecal softener | |
| GB1488709A (en) | Photo-oxidizable compositions and elements | |
| Fiorini et al. | Study of Aging Processes in Two New Al-Mg-Zn Alloys | |
| GB1285849A (en) | 9alpha-FLUORO-16alpha-METHYL-PREGNANE COMPOUNDS | |
| Wilson | Influence of 3 Percent Prestrain on the Creep Strength of Al-2. 5 Percent Cu-1. 2 Percent Mg Alloys at 150 C | |
| CA972350A (en) | 1,2-METHYLENE-17.alpha.-ACYLOXY(OR IMPROVED HYDROXY)-9.beta.,10.alpha.-STEROID COMPOUNDS OF THE PREGNANE SERIES, PHARMACEUTIC PREPARATIONS OF THE BASIS OF THE NOVEL COMPOUNDS AND METHODS OF PRODUCING SAID COMPOUNDS AND PREPARATIONS |